We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$13.5B
AUM Growth
+$456M
Cap. Flow
+$115M
Cap. Flow %
0.85%
Top 10 Hldgs %
14.21%
Holding
2,749
New
241
Increased
902
Reduced
779
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 12.66%
2 Financials 12.63%
3 Healthcare 12.23%
4 Industrials 9.74%
5 Consumer Discretionary 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
1626
DELISTED
Amicus Therapeutics
FOLD
$508K ﹤0.01%
92,989
+11,881
+15% +$83.1K
IRDM icon
1627
Iridium Communications
IRDM
$5.26B
$507K ﹤0.01%
57,065
UPBD icon
1628
Upbound Group
UPBD
$1.11B
$507K ﹤0.01%
41,296
CEMP
1629
DELISTED
Cempra, Inc.
CEMP
$507K ﹤0.01%
30,734
+3,781
+14% +$66.7K
LEA icon
1630
Lear
LEA
$8.16B
$506K ﹤0.01%
4,977
+14
+0.3% +$1.57K
AEGN
1631
DELISTED
Aegion Corp
AEGN
$506K ﹤0.01%
25,950
UBNK
1632
DELISTED
United Financial Bancorp, Inc.
UBNK
$506K ﹤0.01%
39,009
NHC icon
1633
National Healthcare
NHC
$3.47B
$505K ﹤0.01%
7,803
+138
+2% +$8.76K
SEB icon
1634
Seaboard Corp
SEB
$4.02B
$505K ﹤0.01%
176
SRC
1635
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$505K ﹤0.01%
8,817
+726
+9% +$37.9K
CSFL
1636
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$505K ﹤0.01%
32,058
+495
+2% +$7.7K
MACK
1637
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$503K ﹤0.01%
11,864
+337
+3% +$18.4K
ACET
1638
DELISTED
Aceto Corp
ACET
$501K ﹤0.01%
22,892
ARR
1639
Armour Residential REIT
ARR
$2.37B
$500K ﹤0.01%
4,997
-918
-16% -$93.1K
VECO icon
1640
Veeco
VECO
$3.26B
$500K ﹤0.01%
30,184
PRSU
1641
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
$500K ﹤0.01%
16,137
-457
-3% -$14K
PHH
1642
DELISTED
PHH Corporation
PHH
$500K ﹤0.01%
37,567
+437
+1% +$5.67K
CFNL
1643
DELISTED
Cardinal Financial Corp
CFNL
$499K ﹤0.01%
22,736
SUP
1644
DELISTED
Superior Industries International
SUP
$498K ﹤0.01%
18,609
-231
-1% -$5.92K
AMTD
1645
DELISTED
TD Ameritrade Holding Corp
AMTD
$498K ﹤0.01%
17,474
-729
-4% -$22.2K
ZOES
1646
DELISTED
Zoe's Kitchen, Inc.
ZOES
$498K ﹤0.01%
13,738
KERX
1647
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$497K ﹤0.01%
75,108
AROC icon
1648
Archrock
AROC
$5.84B
$496K ﹤0.01%
52,659
-15,553
-23% -$123K
RLYP
1649
DELISTED
RELYPSA INC COM
RLYP
$496K ﹤0.01%
26,794
+3,806
+17% +$66.8K
CCC
1650
DELISTED
Calgon Carbon Corp
CCC
$495K ﹤0.01%
37,630

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2016 Portfolio in Review

As of Q2 2016, Metropolitan Life Insurance Company (MetLife) held 2,749 positions worth $13.5B, up 3.5% from $13B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2016 filing shows 241 new, 902 increased, 779 reduced and 75 closed positions. Its largest new stake was Accenture: 350,604 shares worth $39.7M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2016 buy was Accenture: 350,604 shares worth $39.7M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $49.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $34.2M.
  • Metropolitan Life Insurance Company (MetLife) fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2016, selling an estimated $157M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $13.5B portfolio in Q2 2016.
  • Metropolitan Life Insurance Company (MetLife) opened 241 new positions and closed 75 in Q2 2016.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 3.5% quarter-over-quarter to $13.5B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2016, filed 16 Aug 2016.